{
    "id": "5c8cfca70101eac870000005",
    "question": "Has the protein SIRT2 been associated to cervical cancer?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to consider the role of SIRT2 in cancer biology. SIRT2 is a member of the sirtuin family of proteins, which are NAD+-dependent deacetylases involved in various cellular processes such as aging, metabolism, and stress resistance. Previous studies have implicated sirtuins in cancer development and progression, particularly in terms of their role in maintaining genomic stability and promoting cell survival.\\n\\nSIRT2 has been shown to deacetylate and activate various transcription factors and proteins involved in cell cycle regulation, apoptosis, and DNA repair. In the context of cancer, SIRT2 has been found to be overexpressed in several types of tumors, including breast, prostate, and colon cancer. This overexpression is often associated with poor prognosis and increased tumor aggressiveness.\\n\\nRegarding cervical cancer specifically, there is evidence suggesting that SIRT2 may play a role in the development and progression of this disease. Studies have found that SIRT2 is overexpressed in cervical cancer tissues compared to normal tissues, and its expression is often correlated with advanced tumor stage and poor clinical outcomes. Additionally, SIRT2 has been shown to promote cell proliferation, survival, and migration in cervical cancer cells, suggesting a potential role in tumorigenesis.\\n\\nIn conclusion, based on the available evidence, it appears that SIRT2 has been associated with cervical cancer.\\n\\n\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 39.44387865066528
}